SpringWorks Therapeutics’ $125 Million Series B Financing

Ambrogio Visconti

Goodwin advised SpringWorks Therapeutics, Inc. on the deal SpringWorks Therapeutics, Inc. closed its $125 million Series B preferred stock financing led by Perceptive Advisors. The proceeds…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now